VOLTATTORNI, Carla
 Distribuzione geografica
Continente #
NA - Nord America 6.092
EU - Europa 5.537
AS - Asia 4.127
SA - Sud America 490
AF - Africa 54
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.314
Nazione #
US - Stati Uniti d'America 5.981
RU - Federazione Russa 2.002
SG - Singapore 1.658
GB - Regno Unito 1.611
CN - Cina 1.603
BR - Brasile 410
HK - Hong Kong 363
SE - Svezia 333
FR - Francia 331
FI - Finlandia 306
DE - Germania 296
IE - Irlanda 224
IT - Italia 179
VN - Vietnam 177
UA - Ucraina 131
CA - Canada 76
KR - Corea 71
JP - Giappone 53
IN - India 47
AR - Argentina 34
TR - Turchia 31
BD - Bangladesh 27
MX - Messico 26
BE - Belgio 24
ID - Indonesia 21
ZA - Sudafrica 20
PL - Polonia 18
EC - Ecuador 15
IQ - Iraq 15
NL - Olanda 14
ES - Italia 13
CL - Cile 12
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
MA - Marocco 9
AU - Australia 8
AT - Austria 7
BG - Bulgaria 7
PK - Pakistan 7
UZ - Uzbekistan 7
LV - Lettonia 6
CO - Colombia 5
IL - Israele 5
PY - Paraguay 5
CH - Svizzera 4
EG - Egitto 4
RO - Romania 4
UY - Uruguay 4
EU - Europa 3
GA - Gabon 3
GR - Grecia 3
KE - Kenya 3
PA - Panama 3
PT - Portogallo 3
TG - Togo 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DZ - Algeria 2
JO - Giordania 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
GN - Guinea 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
RW - Ruanda 1
Totale 16.311
Città #
Southend 1.443
Jacksonville 1.060
Singapore 816
Moscow 630
Chandler 621
Woodbridge 564
Dallas 549
Ashburn 441
Ann Arbor 370
Hong Kong 358
Houston 295
Dublin 224
Beijing 216
Jinan 150
Nanjing 138
Wilmington 131
Lawrence 128
Princeton 128
Shenyang 126
The Dalles 121
Los Angeles 96
New York 85
Verona 79
Tianjin 77
Sindelfingen 73
Hebei 72
Changsha 67
Ho Chi Minh City 67
Buffalo 66
Boardman 62
Helsinki 61
Ningbo 53
Nanchang 51
Columbus 50
Haikou 47
Tokyo 47
São Paulo 45
Zhengzhou 44
Milan 43
Munich 40
Hangzhou 39
Hanoi 39
Taiyuan 36
Guangzhou 33
Jiaxing 32
Taizhou 32
Philadelphia 31
Santa Clara 31
Lanzhou 29
San Francisco 28
Redondo Beach 27
Toronto 27
Fuzhou 25
Lancaster 25
Brooklyn 24
Montreal 24
Chicago 22
Seattle 22
Brussels 21
Norwalk 21
Boston 19
Belo Horizonte 18
London 18
Chennai 17
Johannesburg 17
Seoul 17
Warsaw 17
Falls Church 16
Redmond 16
Orem 14
Phoenix 14
Stockholm 14
Auburn Hills 12
Denver 12
Detroit 12
Frankfurt am Main 12
Jakarta 12
Rio de Janeiro 11
Haiphong 9
Clearwater 8
Fairfield 8
Kent 8
Mexico City 8
Quito 8
Riva 8
Berlin 7
Dearborn 7
Dhaka 7
Elora 7
Falkenstein 7
Kemerovo 7
Manaus 7
Manchester 7
Renton 7
Shanghai 7
Tashkent 7
Turku 7
Atlanta 6
Birmingham 6
Charlotte 6
Totale 10.729
Nome #
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 242
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 241
Holo-and apocystalysin from Treponema denticola: two different conformations 238
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 212
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 203
Affinity labelling of pig kidney Dopa decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active site cysteine 196
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 190
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 183
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 179
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 176
Folding defects leading to primary hyperoxaluria 175
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 174
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 171
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 170
Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine) 169
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 167
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 167
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 165
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 159
Chemical modification of pig kidney 3,4-dihydroxyphenylalanine decarboxylase with diethyl pyrocarbonate. Evidence for an essential histidyl residue 157
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 157
Alpha5 pyridoxalacetic acid and alpha5 pyridoxyl-L-phenylalanine acetic acid: their action on some B6-dependent enzymes 156
Aromatic amino acid methyl ester analogs form quinonoidal species with Dopa decarboxylase 154
An affinity labeling reagent for pyridoxal phosphate dependent enzymes 153
Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase 151
An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase 149
Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic 148
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 148
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 147
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 147
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 147
Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase: effects on catalytic properties 143
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 142
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 142
[Preparation and properties of the beta-Hp-Hb complex] 140
Dopa decarboxylase: the pig kidney enzyme primary structure and relationship to other amino acid decarboxylases 140
New insights emerging from recent investigations on human group II pyridoxal 5'-phosphate Decarboxylases 140
[Binding of phosphopyridoxyl derivatives to apoaspartate aminotransferase from wheat germ] 139
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 139
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 139
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 139
[Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids] 137
[Preliminary studies of apo-tyrosine decarboxylase inhibitors] 137
Crystallization and preliminary X-ray analysis of pig kidney DOPA decarboxylase 137
[Action of pyridoxyl-glutamic acid on transaminases] 137
[Binding of pyridoxyl derivatives to apoaspartate transaminase from swine hearts] 136
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 135
[Interaction of dopa decarboxylase from swine kidney with thiosemicarbazone] 134
Dopa decarboxylase 134
Thermodynamic parameters for substrate-coenzyme protein complex formation in b6-dependent enzymes 133
[Separation of pyridoxal phosphate dependent enzymes by means of carboxymethylcellulose hydrazide] 132
A new assay for DOPA decarboxylase activity 132
Structural and functional aspects of the active site in aspartate aminotransferase 132
Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes 130
An abnormal reaction occurring in the presence of L-aromatic aminoacid decarboxylase 129
[Effect of Mg++ ion on 5-nucleotidase activity] 126
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 125
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 124
[Effect of pH on the interaction of 3'-nucleotidase from wheat germ with 5'-phosphate nucleotides] 123
[Study of the inhibition of the 3'-nucleotidase of the wheat germ by 5'-nucleotides] 121
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 121
[Preliminary studies on inhibitors of apo-tyrosine transaminase] 120
DISSOCIATION, UNFOLDING AND REFOLDING TRIALS OF PIG KIDNEY 3,4-DIHYDROXYPHENYLALANINE (DOPA) DECARBOXYLASE 120
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 119
Aromatic L-amino acid decarboxylase. Immunoreactive cells in the tuberal of the carboxyamidomethylcysteine 118
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 118
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 118
Pig kidney dopa decarboxylase: inactivation by iodoacetamide and sequence of the carboxyamidomethylcysteine-containing peptide 117
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 117
Mutation of cysteine 111 in dopa decarboxylase leads to active site perturbation 117
Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catecholaminergic group? 116
Dopa decarboxylase 116
Interaction of aromatic amino acids in D and L forms with 3,4-dihydroxyphenylalanine decarboxylase from pig kidney 114
Mechanism-based inactivation of dopa decarboxylase by serotonin 114
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 113
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 112
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 112
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 112
Time-resolved extrinsic fluorescence of aromatic-L-amino-acid decarboxylase 110
Stereospecificity of sodium borohydride reduction of pig kidney dopa decarboxylase 109
Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities 108
The binding of coenzymes and analogues of the substrate-coenzyme complex to tyrosine aminotransferase 108
Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases 108
The use of 4'-N-(2,4-dinitro-5-fluorophenyl)-pyridoxamine 5'-phosphate 107
Interaction of L-alpha-methyl-alpha-hydrazino-3,4 dihydroxyphenylpropionic acid with dopa-decarboxylase from pig kidney 107
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 107
Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase 107
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 105
Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA 105
Ornithine and glutamate decarboxylases catalyse an oxidative deamination of their alpha-methyl substrates 105
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 105
The binding of nucleotides to 3'-nucleotidase from wheat germ 104
The binding of the coenzyme pyridoxal 5'-phosphate and analogues of the substrate-coenzyme complex to tyrosine decarboxylase 103
Spectral properties of the coenzyme bound to dopa decarboxylase from pig kidney 103
Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase 103
Pig kidney dopa decarboxylase. Structure and function 102
The steady state kinetics of tyrosine decarboxylase from Streptococcus faecalis 100
Reaction of Dopa decarboxylase with alfa-methylDopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active-site directed affinity label 100
Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase 99
Single crystal polarized absorption microspectrophotometry of aromatic L-amino acid decarboxylase 99
Totale 13.686
Categoria #
all - tutte 52.361
article - articoli 49.543
book - libri 0
conference - conferenze 416
curatela - curatele 0
other - altro 393
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.009
Totale 104.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021575 0 0 0 0 0 149 14 123 90 11 151 37
2021/20221.223 116 407 129 45 22 20 12 56 39 19 72 286
2022/20231.973 167 154 185 345 212 432 32 122 226 13 59 26
2023/2024776 42 80 62 188 58 76 25 41 3 22 126 53
2024/20252.545 199 152 38 442 124 43 129 121 398 173 234 492
2025/20264.483 569 322 602 965 1.644 381 0 0 0 0 0 0
Totale 16.428